Elanco (ELAN) — insider trading
Health Care
Elanco (ELAN) has 12 reported SEC Form 4 insider transactions in our data (latest 2026-07-10).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-07-10 | Modi Rajeev A. | Officer (SEE REMARKS) | Grant / award / vesting (derivative) | 60 | $24.82 | $1.5K | Form 4 |
| 2026-07-10 | VanHimbergen Robert M | Officer (EVP and CFO) | Grant / award / vesting (derivative) | 8 | $24.82 | $197 | Form 4 |
| 2026-07-10 | Simmons Jeffrey N | Director, Officer (PRESIDENT, CEO AND DIRECTOR) | Grant / award / vesting (derivative) | 114 | $24.82 | $2.8K | Form 4 |
| 2026-07-07 | VanHimbergen Robert M | Officer (EVP and CFO) | Shares withheld for taxes / exercise cost | 15,336 | $24.64 | $377.9K | Form 4 |
| 2026-07-01 | Kinard David S | Officer (SEE REMARKS) | Grant / award / vesting (derivative) | 25,620 | $0.00 | $0 | Form 4 |
| 2026-06-30 | Anand Kapila K | Director | Grant / award / vesting (derivative) | 584 | $24.61 | $14.4K | Form 4 |
| 2026-06-26 | VanHimbergen Robert M | Officer (EVP and CFO) | Grant / award / vesting (derivative) | 8 | $24.57 | $197 | Form 4 |
| 2026-06-26 | Simmons Jeffrey N | Director, Officer (PRESIDENT, CEO AND DIRECTOR) | Grant / award / vesting (derivative) | 115 | $24.57 | $2.8K | Form 4 |
| 2026-06-26 | Modi Rajeev A. | Officer (SEE REMARKS) | Grant / award / vesting (derivative) | 60 | $24.57 | $1.5K | Form 4 |
| 2026-06-12 | Modi Rajeev A. | Officer (SEE REMARKS) | Grant / award / vesting (derivative) | 61 | $24.17 | $1.5K | Form 4 |
| 2026-06-12 | Simmons Jeffrey N | Director, Officer (PRESIDENT, CEO AND DIRECTOR) | Grant / award / vesting (derivative) | 117 | $24.17 | $2.8K | Form 4 |
| 2026-06-12 | VanHimbergen Robert M | Officer (EVP and CFO) | Grant / award / vesting (derivative) | 8 | $24.17 | $197 | Form 4 |
Ask the chat about ELAN's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: Elanco (ELAN).
Last updated 2026-07-10 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.